NovelStem International Corp.

Novelstem International Corp.

Diagnostics & Research Healthcare Boca Raton, FL, United States NSTM (PNK)

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Diagnostics & Research Companies

View All →

Frequently Asked Questions

Has NovelStem International Corp. had layoffs?
No layoff events have been recorded for NovelStem International Corp. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is NovelStem International Corp. in?
NovelStem International Corp. operates in the Diagnostics & Research industry, within the Healthcare sector.
Is NovelStem International Corp. a publicly traded company?
Yes, NovelStem International Corp. is publicly traded under the ticker symbol NSTM on the PNK. The company has a market capitalization of approximately $0.00 billion.
Where is NovelStem International Corp. headquartered?
NovelStem International Corp. is headquartered in Boca Raton, FL, United States at 2255 Glades Road, Boca Raton, FL 33431, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.